Rosacea is a common, chronic inflammatory facial eruption of unknown cause. It is more prevalent in women than in men, and disease onset typically occurs after age 30. Rosacea is characterized by erythema,…
Med Lett Drugs Ther. 2024 Feb 5; 66(1695):21-2 doi:10.58347/tml.2024.1695b
Rosacea is a common, chronic inflammatory facial eruption of unknown cause. It is more prevalent in women than in men, and disease onset typically occurs after age 30. Rosacea is characterized by erythema, telangiectasia, and flushing, and sometimes by recurrent, progressive crops of acneiform papules and pustules, usually on the central part of the face. Some patients develop granulomas and tissue hypertrophy, which may lead to rhinophyma (a bulbous nose), particularly in men. Blepharitis and conjunctivitis are common. Keratitis and corneal scarring occur rarely.
Topical ivermectin lotion 0.5% (Sklice, and generics), which has been available by prescription since 2012, is now FDA-approved for sale over the counter (OTC) for treatment of head lice in patients ≥6…
Med Lett Drugs Ther. 2023 Jun 26; 65(1679):103-4 doi:10.58347/tml.2023.1679e
Topical ivermectin lotion 0.5% (Sklice, and generics), which has been available by prescription since 2012, is now FDA-approved for sale over the counter (OTC) for treatment of head lice in patients ≥6 months old. Ivermectin is also available by prescription as a 1% cream (Soolantra) approved for topical treatment of inflammatory lesions of rosacea and in oral tablets ( Stromectol , and generics) for treatment of various parasitic infections.
The FDA has approved a 1.5% topical foam formulation of minocycline ( Zilxi – Foamix) for treatment of inflammatory lesions of rosacea in adults. It is the only topical minocycline product approved for this…
Med Lett Drugs Ther. 2020 Nov 16; 62(1611):179-80
The FDA has approved a 1.5% topical foam formulation of minocycline ( Zilxi – Foamix) for treatment of inflammatory lesions of rosacea in adults. It is the only topical minocycline product approved for this indication. The same manufacturer markets minocycline foam 4% (Amzeeq) for treatment of acne in patients ≥9 years old.
The FDA has approved the selective alpha 1A -adrenergic receptor agonist oxymetazoline as a 1% cream ( Rhofade – Allergan) for topical treatment of persistent facial erythema of rosacea in adults.…
Med Lett Drugs Ther. 2017 May 22; 59(1521):84-6
The FDA has approved the selective alpha 1A -adrenergic receptor agonist oxymetazoline as a 1% cream ( Rhofade – Allergan) for topical treatment of persistent facial erythema of rosacea in adults. Brimonidine, a selective alpha 2 -adrenergic receptor agonist, was approved in 2013 as a 0.33% gel ( Mirvaso) for the same indication. Like Mirvaso , Rhofade is not indicated for treatment of inflammatory lesions of rosacea. Oxymetazoline has been available over the counter for many years as a nasal decongestant spray ( Afrin , and others).
This common, chronic inflammatory facial eruption of unknown cause is more prevalent in women than in men. Rosacea is characterized by erythema and telangiectasia, and sometimes by recurrent, progressive crops…
Med Lett Drugs Ther. 2016 Feb 1; 58(1487):16-7
This common, chronic inflammatory facial eruption of unknown cause is more prevalent in women than in men. Rosacea is characterized by erythema and telangiectasia, and sometimes by recurrent, progressive crops of acneiform papules and pustules, usually on the central part of the face. Some patients develop granulomas and tissue hypertrophy, which may lead to rhinophyma (a bulbous nose), particularly in men. Blepharitis and conjunctivitis are common. Keratitis and corneal scarring occur rarely.
The FDA has approved a 1% cream formulation of the antiparasitic drug ivermectin ( Soolantra – Galderma) for topical treatment of inflammatory lesions of rosacea. Ivermectin is available in the US in tablets…
Med Lett Drugs Ther. 2015 Apr 13; 57(1466):51-2
The FDA has approved a 1% cream formulation of the antiparasitic drug ivermectin ( Soolantra – Galderma) for topical treatment of inflammatory lesions of rosacea. Ivermectin is available in the US in tablets ( Stromectol , and generics) for treatment of onchocerciasis and other worm infestations and as a 0.5% lotion (Sklice) for treatment of head lice.